Largest health care pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 health care pharmaceutical companies ranked by total assets, at AED 764.5B, ahead of Johnson & Johnson (AED 731.6B) and Sanofi (AED 516.7B). Figures as of 19 Nov 2026, 16:24 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerAED 764.5B
- Median
- AED 12.9B
- Combined market value
- AED 18.21T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | AED 764.5B | AED 577.1B | AED 101.26 | 1.75% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | AED 731.6B | AED 2.34T | AED 972.98 | 2.85% down | 34% up | ||
| 3 | SanofiSNY · Health Care | AED 516.7B | AED 403.8B | AED 168.15 | 2.83% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | AED 502.7B | AED 1.21T | AED 490.62 | 3.04% down | 45% up | ||
| 5 | AbbVieABBV · Health Care | AED 492B | AED 1.82T | AED 1,031.28 | 1.82% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | AED 419B | AED 992.3B | AED 639.84 | 2.54% down | 1% up | ||
| 7 | Eli LillyLLY · Health Care | AED 413.1B | AED 4.42T | AED 4,957.92 | 2.37% down | 33% up | ||
| 8 | NovartisNVS · Health Care | AED 407.5B | AED 1.05T | AED 555.40 | 2.57% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | AED 356.8B | AED 249.9B | AED 78.23 | 0.14% up | 51% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | AED 330.7B | AED 437.8B | AED 214.19 | 2.08% down | 30% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | AED 318.5B | AED 664.8B | AED 383.85 | 0.03% up | 16% down | ||
| 12 | GSKGSK · Health Care | AED 297.9B | AED 351.7B | AED 175.48 | 1.65% down | 5% up | ||
| 13 | Novo NordiskNVO · Health Care | AED 295.9B | AED 628B | AED 142.48 | 1.61% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | AED 149.7B | AED 171.1B | AED 146.61 | 5.47% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | AED 149B | AED 354B | AED 3,422.37 | 1.45% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | AED 136.6B | AED 83.6B | AED 72.88 | 2.14% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | AED 94.2B | AED 488.2B | AED 1,925.67 | 2.26% down | 27% up | ||
| 18 | GrifolsGRFS · Health Care | AED 80.3B | AED 20.7B | AED 30.47 | 2.07% down | 0% up | ||
| 19 | Royalty PharmaRPRX · Health Care | AED 72.1B | AED 143.1B | AED 248.81 | 1.35% down | 79% up | ||
| 20 | ZoetisZTS · Health Care | AED 56.8B | AED 122.5B | AED 301.60 | 4.03% down | 26% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | AED 49.1B | AED 48.7B | AED 97.34 | 0.73% down | 26% up | ||
| 22 | GenmabGMAB · Health Care | AED 47.3B | AED 117.8B | AED 191.02 | 2.04% up | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | AED 42.8B | AED 56.9B | AED 886.32 | 2.60% down | 41% up | ||
| 24 | BeOne MedicinesONC · Health Care | AED 30.1B | AED 168.8B | AED 1,477.78 | 0.30% down | 16% up | ||
| 25 | United TherapeuticsUTHR · Health Care | AED 28.9B | AED 88.3B | AED 2,074.30 | 2.17% down | 22% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | AED 27.9B | AED 44.7B | AED 230.76 | 2.28% up | 17% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | AED 22.6B | AED 45.4B | AED 54.50 | 0.93% down | 8% up | ||
| 28 | Roivant SciencesROIV · Health Care | AED 21B | AED 104.9B | AED 144.78 | 1.78% up | 91% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | AED 18.2B | AED 73.2B | AED 546.70 | 0.36% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | AED 13.5B | AED 27.4B | AED 78.54 | 2.26% down | 90% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | AED 12.9B | AED 16.5B | AED 99.22 | 1.37% down | 63% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | AED 10.6B | AED 18.5B | AED 221.63 | 0.19% up | 21% down | ||
| 33 | AlkermesALKS · Health Care | AED 9.1B | AED 28.6B | AED 170.08 | 1.15% down | 66% up | ||
| 34 | InsmedINSM · Health Care | AED 8.3B | AED 115.3B | AED 525.60 | 19.46% up | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | AED 6.4B | AED 11.6B | AED 59.55 | 0.22% down | 41% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | AED 5.7B | AED 21.4B | AED 1,070.28 | 2.44% down | 50% up | ||
| 37 | Ascendis PharmaASND · Health Care | AED 5.3B | AED 63.9B | AED 974.29 | 1.87% down | 29% up | ||
| 38 | CytokineticsCYTK · Health Care | AED 5.2B | AED 26.3B | AED 188.70 | 0.12% up | 19% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | AED 5.1B | AED 22.6B | AED 159.76 | 0.90% up | 13% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | AED 4.6B | AED 34.5B | AED 1,483.15 | 1.44% up | 27% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | AED 3.9B | AED 36.9B | AED 244.34 | 0.62% up | 117% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | AED 3.4B | AED 32.7B | AED 1,171.33 | 4.50% up | 86% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | AED 3.4B | AED 17.9B | AED 103.13 | 0.97% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | AED 3.4B | AED 55.9B | AED 287.02 | 0.18% up | 21% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | AED 3.1B | AED 22.7B | AED 347.69 | 2.36% up | 34% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | AED 3.1B | AED 26.5B | AED 241.73 | 2.91% down | 10% down | ||
| 47 | Belite BioBLTE · Health Care | AED 2.9B | AED 22.8B | AED 561.41 | 2.16% down | 43% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | AED 2.9B | AED 34.6B | AED 363.84 | 2.36% down | 332% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | AED 2.8B | AED 27.3B | AED 348.04 | 0.30% down | 129% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | AED 2.8B | AED 30.9B | AED 38.69 | 0.33% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | AED 2.5B | AED 25.9B | AED 493.10 | 0.19% up | 6% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | AED 2.5B | AED 30.3B | AED 464.58 | 0.52% down | 51% up | ||
| 53 | ABIVAXABVX · Health Care | AED 2.4B | AED 27B | AED 308.87 | 0.32% up | 32% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | AED 2.2B | AED 17.5B | AED 182.53 | 1.07% down | 45% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | AED 2B | AED 16.5B | AED 150.84 | 0.73% down | 86% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | AED 1.9B | AED 17.7B | AED 314.03 | 1.82% up | 108% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | AED 1.8B | AED 24.5B | AED 361.28 | 2.75% up | 255% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | AED 1.8B | AED 29.7B | AED 428.53 | 1.98% down | 18% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | AED 1.6B | AED 14.5B | AED 105.74 | 1.13% down | 168% up | ||
| 60 | ErascaERAS · Health Care | AED 1.5B | AED 18.2B | AED 51.93 | 2.76% up | 395% up | ||
| 61 | VeradermicsMANE · Health Care | AED 560.5M | AED 19.2B | AED 456.08 | 0.54% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6727 AED).
Questions and answers
Which health care pharmaceutical companies rank first by total assets?
Pfizer (AED 764.5B), Johnson & Johnson (AED 731.6B) and Sanofi (AED 516.7B) are the top three of the 61 health care pharmaceutical companies ranked by total assets as of 19 Nov 2026, 16:24 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total assets have a combined market value of AED 18.21T as of 19 Nov 2026, 16:24 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.